Literature DB >> 27641267

Angioglioma of the Spinal Cord.

Krishna Chaitanya Joshi1, Kiran Khanapure2, Nishchit Hegde2, Niveditha Ravindra3, Aniruddha T Jagannatha2, Alangar S Hegde2.   

Abstract

BACKGROUND: Angiogliomas are rare low-grade glial tumors with significant vascular components. These tumors are usually seen in the brain, and spinal cord angiogliomas have not been reported in the literature until now. CASE DESCRIPTION: We report the case of a 15-year-old boy with an angioglioma of the medulla and cervicodorsal spine, which was completely excised through a combined suboccipital craniotomy and cervicodorsal laminotomy. The patient experienced excellent clinical recovery after the surgery, and follow-up contrast magnetic resonance imaging showed complete excision of the tumor.
CONCLUSION: The fact that increased vascularity in a glioma does not always indicate a higher grade is confirmed by the unique histology of angiogliomas. These tumors can present with intratumoral bleeding. Awareness of these entities is extremely important. Complete excision can be attempted, and the postoperative prognosis is very good. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angioglioma; Spinal tumor

Mesh:

Year:  2016        PMID: 27641267     DOI: 10.1016/j.wneu.2016.09.032

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  2 in total

1.  Case Report of a Hemangioblastoma With Large Blood Vessels and Rare Vascular Anomalies: Is It Fibromuscular Dysplasia or Arteriovenous Malformation Association?

Authors:  Luis A Rodríguez-Hernández; Marcos V Sangrador-Deitos; Humberto Montano-Tello; Michel Mondragon-Soto; Martha Lilia L Tena Suck
Journal:  Cureus       Date:  2022-04-27

2.  Glioblastoma Multiforme Associated with Arteriovenous Malformation: A Case Report and Literature Review.

Authors:  Thara Tunthanathip; Kanet Kanjanapradit
Journal:  Ann Indian Acad Neurol       Date:  2020 Jan-Feb       Impact factor: 1.383

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.